Presentation
The Innovation Department invites you to meet & greet our next speaker in the series, Gemma Guinart, Principal at Invivo Partners.
Invivo Partners is a venture capital firm specializing in early-stage healthcare companies.
Gemma will share her career and experience in the healthcare i/o life sciences sector from an investor's point of view, giving insights for researchers.
Bridges to Industry is a meet & greet programme set up by the Innovation Dept. It provides participants the opportunity to meet key professionals in the bio sector and expand and/or consolidate a professional network. Schedule of the session:
- Presentation by the Invited Speaker about her career and experience in the healthcare i/o life sciences sector from an investor's point of view
- Q&A session
- Closing remarks
Sessions are open to all IRB members (places limited). In addition, a number of places are reserved for IRB Barcelona alumni.
If you wish to participate in this session, please register before 28 November(Registration Form). Alumni should contact us at innovation@irbbarcelona.org.
Speaker: Gemma Guinart, Principal at Invivo Partners.
Date: Thursday, 4 December 2025, 16:00-17:00.
Place: Sala 1 Torres R, Parc Científic de Barcelona (PCB).
Language: English
Audience: Open to the entire IRB Barcelona community (places limited)
Speakers
Gemma Guinart, Principal at Invivo Partners.
Gemma Guinart is Principal at Invivo Partners, a Barcelona-based venture capital firm focused on early-stage investments and technology transfer in innovative areas of drug development. Invivo manages three funds with an investor base that includes major institutional investors such as the European Investment Fund, Instituto de Crédito Oficial (ICO), Institut Català de Finances (ICF), Institut Valencià de Finances (IVF), the Barcelona City Council, and a majority of private investors. Within Invivo, Gemma serves as Board Observer at Telomere Therapeutics, Integra Therapeutics, Telum Therapeutics, Peptomyc, and Signadori Bio.
Before joining Invivo, she worked in technology transfer at UPF Ventures, supporting the creation and financing of academic spin-offs. She holds a BSc in Biomedical Sciences from the University of Barcelona, an MSc in Business Management Applied to Biotechnology from the Biotechnology Business Institute, and a Postgraduate Certificate in Financial Management from UPF Barcelona School of Management.